Camber is pleased to announce that 22 new generic products were added to the company’s portfolio in the last 6 months! The organization expects launches to accelerate in the second half of 2023.
- Naproxen Sodium Tablets (generic for Aleve®)
- Promethazine HCI Suppositories, USP (generic for Phenergan®)
- Trientine Hydrochloride Capsules, USP (generic for Syprine®)
- Posaconazole DR Tablets (generic for Noxafil®)
- Ezetimibe Tablets (generic for Zetia®)
- Roflumilast 250 mcg Tablets (generic for Daliresp®)
- Zileuton ER Tablets (generic for Zyflo CR®)
- Valganciclovir for Oral Solution (generic for Valcyte®)
- Ranolazine ER Tablets (generic for Ranexa®)
- Linezolid for Oral Suspension (generic for Zyvox®)
- Levothyroxine Sodium Tablets, USP (generic for Thyro-Tabs®)
- Pantoprazole Sodium for Injection (generic for Protonix®)
- Aminocaproic Acid Oral Solution, USP (generic for Amicar®)
- Teriflunomide Tablets (generic for Aubagio®)
- Diclofenac Potassium Oral Solution (generic for Cambia®)
- Sapropterin Dihydrochloride PFOS (generic for Kuvan® OS)
- Sapropterin Dihydrochloride Tablets (generic for Kuvan®)
- Deferasirox Oral Granules (generic for Jadenu® Sprinkle)
- Memantine HCl Tablets (generic for Namenda®)
- Vancomycin HCl Injection
- Mexiletine HCl Capsules (generic for Mexitil®)
- Daptomycin for Injection, 350 mg/Vial (of Sagent Pharmaceuticals)
Contact your Camber representative to learn more about these exciting launches and future opportunities.
